U.S. study: Infected with Omitron, less likely to observe

The records of a feasibility study in the United States point to a lower risk of lying in hospitals and death by the Omitron version of the coronary. The study has been conducted by analyzing almost 70,000 people who resulted in positive results in COVID-19. Tests were conducted by data obtained from the health system in California [...]
The study has been conducted by analyzing almost 70,000 people who resulted in positive results in COVID-19. Tests were conducted by data obtained from California's health system between November 30th and January 1, where two variants of coronary, Delta, and Omitron were widely circulated.
The study found that people infected with Omitron were half less likely to be hospitalized, about 75 percent were less likely for intensive care, and about 90 percent were less likely to die than those infected with the Delta version.
Of the nearly 52,000 people infected with Omitron, none of them needed ventilation, compared to 11 of the almost 17,000 infected with the Delta version.
These findings are added to research conducted in other countries, including South Africa and Britain. These studies also revealed that Omitron infections are less serious and less likely to cause death.
The results of these studies suggest Omitron is the least serious “” that Delta and the reduction of likelihood of developing a serious illness is not only the result of the vaccine or previous infection, the study said.
However, this study has not yet been examined by other scientists, so the Centers for Disease Control and Prevention (CDC) said that the data is not taken for granted.
CDC Director Rochell Walensky told reporters that Omitron's extreme transmission is still burdening the American health system.
The US is currently registering an average of 750,000 new cases per day and has about 150,000 surveillances from COVIDD-19. This country is also registering over 1,600 victims on daily bases.











